Positron Exhibits at the American Society of Nuclear Cardiology Annual Conference to Promote Their Cardiac Optimized Pet Scanner

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minnesota October 1-4, 2009 to showcase their newly developed cardiac optimized PET scanner, the Attrius(TM) (www.asnc.org).

The ASNC meeting offers a unique combination of cutting-edge science and practical clinical applications. Over 1,200 physicians, scientists and technologists from every practice setting attend the ASNC Annual Scientific Session for unparalleled professional education, career enhancement and to renew their commitment to the profession.

Joseph Oliverio, Chief Technology Officer of Positron states, "The ASNC conference attracts the highest concentration of our sales targets, nuclear cardiologists and practice administrators. Positron will use this opportunity to showcase their newly designed, cardiac optimized PET scanner, the Attrius(TM), to thousands of potential buyers. The demand for Cardiovascular PET imaging is rapidly increasing as it enables the physician to provide better patient care, accurate diagnoses, and the potential to reduce unnecessary procedures and radiation exposure." Mr. Oliverio also went on to state, "The Attrius(TM) has a small footprint, robust standard cardiovascular software package, competitive scan times and an affordable cost of entry making the Attrius(TM) the right choice for enhancing the capabilities of a Cardiovascular practices, while providing better care."

About Positron: Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include: the Attrius(TM), a PET imaging device; the Pulse(R), a SPECT imaging device; the Nuclear Pharm-Assist(R), an automated radiopharmaceutical distribution device; and the Tech-Assist(TM), a radiopharmaceutical injection shield. More information about Positron is available at www.positron.com.

Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.

For further information please contact Positron Corporation at (317)576-0183.

SOURCE: Positron Corporation

Positron Corporation 
Joseph Oliverio, (317)576-0183

Related terms: cardiovascular, career, clinical, community, conference, education, medicine, minnesota, nuclear, physicians, products, sales, scanner, science, software